12月17日，激光雷达"芯片第一案"迎来最新交锋。 深圳市灵明光子科技有限公司（以下简称"灵明光子"）通过其官方网站发布声明，将以"专利侵权"为由反诉速腾聚创。此举距离其12月10日公开声称"未 收到法律函件"仅过去一周。 专利实力7：100，灵明光子反诉策略承压 从公开信息看，灵明光子的技术轨迹存在显著反差。公司自2018年成立后，长期专注于消费电子级的小面阵SPAD传感器。 然而，在2023年3月与速腾聚创终止合作后，仅用约半年时间便推出了高分辨率的大面阵芯片。这一快速的技术跃迁引发行业关注，因为此类高性能 SPAD-SoC芯片的研发，即便是经验成熟的团队，常规开发周期也需要18至24个月。 更为关键的是，灵明光子尚未公开回应速腾聚创声明提及的内容。根据速腾聚创的官方声明，"其已完成深入调查与专业取证，并形成完整证据链，固定 了涉及其SoC芯片核心技术的关键信息点，以及灵明光子员工涉嫌获取技术秘密等内容。" 同日，深圳市速腾聚创科技有限公司（以下简称"速腾聚创"）发布官方声明回应，"重申灵明光子涉嫌侵害其技术秘密才是本次争议的核心，并透露已采 取包括专利侵权反诉、商业诋毁诉讼及请求宣告专利无效在内的多重法 ...

Core Viewpoint - The commercial dispute between CATL, the industry leader, and Haicheng Energy, a rising star in energy storage, has intensified due to allegations of trade secret infringement involving a key executive from Haicheng Energy [1][2]. Group 1: Company Background - Haicheng Energy was established on December 27, 2019, focusing on the research, production, and sales of lithium battery core materials and lithium iron phosphate energy storage batteries [1]. - The company plans to go public in Hong Kong on March 25, 2025, and has experienced rapid revenue growth, with projected revenue of 12.9 billion yuan in 2024 and a valuation of 25 billion yuan [1][7]. - Haicheng Energy's lithium-ion energy storage battery shipment volume is expected to rank third globally in 2024, with a market share of 11% [7]. Group 2: Legal Disputes - Since 2023, CATL has initiated multiple legal actions against Haicheng Energy, including a lawsuit for breach of non-compete agreements and claims of unfair competition, seeking 150 million yuan in damages [2][6]. - The latest legal action involves the arrest of Feng Dengke, a former executive at Haicheng Energy, accused of infringing trade secrets, marking CATL's fourth legal move against the company [1][2]. Group 3: Patent Competition - As of June 2025, CATL holds 49,347 patents, significantly outnumbering Haicheng Energy's 3,900 patents, highlighting a substantial gap in intellectual property [1][7]. - The patent dispute centers around a composite electrolyte patent, with claims that Haicheng Energy's technology closely resembles CATL's, differing only by 4.4% in energy density [2][5]. Group 4: Executive Background - Many key executives at Haicheng Energy, including its founder Wu Zuyu, have previous experience at CATL, contributing to the company's rapid rise in the energy storage sector [6][7]. - The company has seen a compound annual growth rate of 167% in lithium-ion energy storage battery shipments from 2022 to 2024 [7].

Core Viewpoint - The commercial dispute between Ningde Times and Haicheng Energy Storage has gained attention due to a "help request letter" from the wife of a former executive at Haicheng, who was arrested for allegedly infringing on trade secrets. This incident highlights the ongoing patent conflict between the two companies, with Haicheng's IPO facing uncertainties as a result [2][10]. Company Overview - Haicheng Energy Storage, founded on December 27, 2019, focuses on the research, production, and sales of lithium battery core materials and lithium iron phosphate energy storage batteries. The company plans to list on the Hong Kong Stock Exchange on March 25, 2025 [3][10]. - As of 2024, Haicheng is the only company in the GWh-level lithium-ion battery shipment category that specializes in the energy storage sector, ranking third globally in energy storage battery shipments [3]. Market Position and Performance - In 2024 and the first half of 2025, Ningde Times maintained its position as the global leader in energy storage battery sales, with shipments of 93 GWh and 55 GWh, respectively [4]. - Haicheng's energy storage battery shipments grew at a compound annual growth rate of 167% from 2022 to 2024, reaching 35.1 GWh in 2024, capturing an 11% market share [15]. Financial Performance - Haicheng's revenue has seen rapid growth, with figures of 3.615 billion yuan, 10.202 billion yuan, and 12.917 billion yuan from 2022 to 2024, representing a 2.57-fold increase over two years. The company turned a profit in 2024, achieving a net profit of 318 million yuan after adjustments [15]. Patent Dispute - The patent conflict between Ningde Times and Haicheng has escalated, with Ningde Times filing multiple lawsuits against Haicheng, including a claim for 150 million yuan for unfair competition [4][10]. - As of June 2025, Ningde Times holds 49,347 patents, significantly outnumbering Haicheng's 3,900 patents [15]. Key Personnel and Background - Haicheng's key personnel, including its founder Wu Zuyu, have backgrounds in Ningde Times, which has contributed to the company's rapid rise. Wu worked at Ningde Times for over seven years before founding Haicheng [10][11].

Core Viewpoint - The legal dispute between Masimo and Apple centers around the blood oxygen functionality in Apple Watches, with Masimo alleging that U.S. Customs and Border Protection (CBP) improperly allowed Apple to import watches equipped with pulse oximeter technology without consulting Masimo [1][3]. Group 1: Legal Dispute - Masimo has filed a lawsuit against CBP in federal court, claiming that the agency reversed its previous decision regarding the importation of Apple Watches with blood oxygen reading capabilities without notifying Masimo [3]. - The conflict between Masimo and Apple has been ongoing, with Masimo accusing Apple of poaching its employees and stealing technology for the pulse oximeter used in Apple Watches [3]. - In 2023, Masimo successfully convinced the U.S. International Trade Commission (ITC) to block the import of Apple Series 9 and Ultra 2 smartwatches due to patent infringement related to blood oxygen level reading technology [3]. Group 2: Recent Developments - On August 14, Apple announced it would reintroduce the blood oxygen reading feature in its smartwatches, contingent upon CBP's approval, which Masimo argues was granted without proper consultation [3]. - Masimo contends that CBP's actions undermine its rights and responsibilities, emphasizing that the agency should enforce the ITC's exclusion order rather than create loopholes [3]. - Masimo is seeking a court order to halt CBP's decision and prevent Apple from selling watches with blood oxygen functionality [3].